Melatonin May Help Reduce Prostate Cancer Risk

Prostate cancer risk may be reduced by melatonin

 

Higher levels of melatonin, a hormone involved in the sleep-wake cycle, may suggest decreased risk for developing advanced prostate cancer, according to results presented at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research, held Jan. 18-21. Melatonin is a hormone that is produced exclusively at night in the dark and is an important output of the circadian rhythm, or the body’s inherent 24-hour clock. Many biological processes are regulated by the circadian rhythm, including the sleep-wake cycle. Melatonin may play a role in regulating a range of other hormones that influence certain cancers, including breast and prostate cancers.

Find out more here: http://www.medicalnewstoday.com/releases/271428.php

 

Sharing This

About John Montague DC

John Montague DC is the owner of WebVitamins. He is active in the industry and is currently president of the NPA East.

Speak Your Mind

*

Sharing This

facebooktwittergoogle_pluspinterestmailby feather